South Africa recalls compounded GLP-1 medicines over serious safety concerns
South African health regulators have ordered the immediate recall of several compounded GLP-1 medicines, warning that the products pose a serious risk to patient safety and should no longer be prescribed, dispensed or used. The recall was announced by the South African Health Products Regulatory Authority (SAHPRA) in partnership with the South African Pharmacy Council…
